Prevalence, causes and impact of TP53-loss phenocopying events in human tumors
Abstract Background TP53 is a master tumor suppressor gene, mutated in approximately half of all human cancers. Given the many regulatory roles of the corresponding p53 protein, it is possible to infer loss of p53 activity – which may occur due to alterations in trans – from gene expression patterns...
Main Authors: | Bruno Fito-Lopez, Marina Salvadores, Miguel-Martin Alvarez, Fran Supek |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-04-01
|
Series: | BMC Biology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12915-023-01595-1 |
Similar Items
-
Exploring the Functions of Mutant p53 through <i>TP53</i> Knockout in HaCaT Keratinocytes
by: Daniil Romashin, et al.
Published: (2024-02-01) -
TP53 GENE MUTATIONS – FROM GUARDIAN OF THE GENOME TO ONCOGENE
by: Petar Babović, et al.
Published: (2010-03-01) -
p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations
by: You-Na Sung, et al.
Published: (2022-12-01) -
Risk stratification for lung adenocarcinoma on EGFR and TP53 mutation status, chemotherapy, and PD‐L1 immunotherapy
by: Chih‐Hsun Wu, et al.
Published: (2019-10-01) -
Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumors
by: Dmitriy Sonkin
Published: (2015-10-01)